VanEck Pharmaceutical ETF
101 hedge funds and large institutions have $404M invested in VanEck Pharmaceutical ETF in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
0% more funds holding
Funds holding: 101 → 101 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
12.41% less ownership
Funds ownership: 107.08% → 94.67% (-12%)
Holders
101
Holding in Top 10
1
Calls
$551K
Puts
$112K
Top Buyers
| 1 | +$42.5M | |
| 2 | +$12.2M | |
| 3 | +$12M | |
| 4 |
IAA
Independent Advisor Alliance
Charlotte,
North Carolina
|
+$3.92M |
| 5 |
Morgan Stanley
New York
|
+$2.32M |
Top Sellers
| 1 | -$27.6M | |
| 2 | -$22.8M | |
| 3 | -$11.9M | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$3.71M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.49M |